This topic contains a solution. Click here to go to the answer

Author Question: Which of the following, if observed in a client undergoing barbiturate withdrawal, would require the ... (Read 37 times)

lbcchick

  • Hero Member
  • *****
  • Posts: 550
Which of the following, if observed in a client undergoing barbiturate withdrawal, would require the nurse to contact the physician?
 
  1. Labile BP, lassitude, insomnia
  2. Nausea, vomiting, tremors
  3. Dilated pupils, flushed skin, diaphoresis
  4. Muscle twitching, seizures, delirium

Question 2

The ED nurse managing care for a client who has ingested PCP should create an environment for the client that is:
 
  1. Challenging and educational
  2. Active and stimulating
  3. Simplified and safe
  4. Like any room in the ED



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

matt

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

ANS: 4
The most life-threatening symptoms from barbiturate withdrawal are those listed in option 4. The nurse should contact the physician if these occur.

Answer to Question 2

ANS: 3
Since PCP is a hallucinogen, the nurse should not provide a challenging (option 1) environment or an active one (option 2). A room that is safer than the usual ED room would be best (option 3).





 

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library